ENTRY       D11702                      Drug
NAME        Givosiran (USAN/INN)
FORMULA     C524H694F16N173O316P43S6
EXACT_MASS  16292.034
MOL_WEIGHT  16300.3229
REMARK      ATC code: A16AX16
            Chemical structure group: DG03084
            Product (DG03084): D11708<JP/US>
EFFICACY    Accumulation reduction (neurotoxic intermediates)
  TYPE      RNA interference (RNAi) drug
COMMENT     Treatment of acute hepatic porphyria
TARGET      ALAS1 [HSA:211] [KO:K00643] (mRNA)
  PATHWAY   hsa00860(211)  Porphyrin metabolism
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX16 Givosiran
                  D11702  Givosiran (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Acyltransferases
                ALAS1
                 D11702  Givosiran (USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11702
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11702
DBLINKS     CAS: 1639325-43-1
            PubChem: 405226568
///
